venusconcept.com - VERO Company Value to Revenue Ratio

Public company logo of Venus Concept (VERO)

High barriers to entry created by patents and lobbying established the foundation for Venus Concept Inc. (VERO). The enterprise value-to-revenue ratio visualizes this trend, where the 0.00 level captures the current state. Revenue later stabilized thanks to ancillary services and replacement parts. The company is currently undergoing restructuring, optimizing its product portfolio to drive profit growth.

VERO Venus Concept Inc.: EV/Sales Multiple in the range 11/23/2025 - 02/21/2026

VERO (Venus Concept Corp): analytical breakdowns and indicator data

Fundamental valuation:Venus Concept Inc. VERO
Mass-produced product of Venus Concept Inc

Venus Concept Inc. (VERO) integration into a closed-loop aesthetic medicine ecosystem via services and subscriptions generates a stable revenue stream that serves as the basis for calculating this indicator. An analysis of the firm's valuation using the EV/Sales multiple allows for the determination of the business's market value accounting for net debt, where the momentum of the smoothed line helps distinguish fundamental growth from speculative asset overheating.

Competitor analysis for Venus Concept Inc.

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|IINN: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SeaStar Medical (ICU)|Enterprise Value-to-Revenue Ratio iridex.com|Company Value to Revenue Ratio INBS (Intelligent Bio Solutions Inc.)|Company Value to Revenue XAIR (Beyond Air, Inc.)|PFSA - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple SSKN (STRATA Skin Sciences Inc.)|GCTK - Company Value to Revenue|NAOV: Company Value to Revenue|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)